Survival of grafts of genetically modified cardiac myocytes transfected with FITC-labeled oligodeoxynucleotides and the β-galactosidase gene in the noninfarcted area, but not the myocardial infarcted area

Search this article

Journal

  • Gene Therapy

    Gene Therapy 4 (2), 120-127, 1997-02-01

    Springer Science and Business Media LLC

Citations (4)*help

See more

Details 詳細情報について

Report a problem

Back to top